Published in J Arrhythm on August 31, 2017
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med (2002) 27.55
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med (1996) 15.04
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med (2016) 7.87
Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med (2008) 5.13
Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation (2002) 3.74
Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation (2003) 1.90
Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. J Am Coll Cardiol (2009) 1.88
Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure. Int J Cardiol (2001) 1.71
Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema. Am Heart J (2002) 1.65
Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. Circ Arrhythm Electrophysiol (2012) 1.60
The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol (2000) 1.57
Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation (2001) 1.56
Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation (2000) 1.22
Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation (1993) 1.21
Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). Circ J (2012) 1.21
Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol (2002) 1.15
Release of cardiac troponin in acute coronary syndromes: ischemia or necrosis? Clin Chim Acta (1999) 1.15
Erratum to '2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing' [Journal of Arrhythmia 32/1 (2016) 1-28]. J Arrhythm (2016) 1.11
Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant (2000) 1.08
Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag (2008) 1.05
Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J (2005) 0.96
Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies. Heart Vessels (2006) 0.91
Impaired regional subendocardial coronary flow reserve in conscious dogs with pacing-induced heart failure. Am J Physiol (1993) 0.87
Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD). Circ Arrhythm Electrophysiol (2014) 0.85
Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med (2003) 0.84
The defibrillator in acute myocardial infarction trial (DINAMIT): study protocol. Am Heart J (2000) 0.82
Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Heart Rhythm (2014) 0.80
Baseline Troponin T Levels Modulate the Effects of ICD Shocks on All-Cause Mortality. J Am Coll Cardiol (2015) 0.80
Renal dysfunction and heart failure: things are seldom what they seem. Eur Heart J (2013) 0.79
Circulating heart-type fatty acid-binding protein levels predict ventricular fibrillation in Brugada syndrome. J Cardiol (2015) 0.76
Complementary Role of Arm Circumference to Body Mass Index in Risk Stratification in Heart Failure. JACC Heart Fail (2016) 1.38
Quadriceps Strength as a Predictor of Mortality in Coronary Artery Disease. Am J Med (2015) 0.84
Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Heart Vessels (2015) 0.83
Sudden cardiac arrest recorded during Holter monitoring: prevalence, antecedent electrical events, and outcomes. Heart Rhythm (2014) 0.83
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial. Cardiovasc Diabetol (2016) 0.79
Safety of neuromuscular electrical stimulation in patients implanted with cardioverter defibrillators. J Electrocardiol (2015) 0.77
Ezetimibe enhances and stabilizes anticoagulant effect of warfarin. Heart Vessels (2016) 0.76
Polytherapy with sodium channel-blocking antiepileptic drugs is associated with arrhythmogenic ST-T abnormality in patients with epilepsy. Seizure (2016) 0.76
An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting. J Arrhythm (2015) 0.75
Population pharmacokinetics and optimization of the dosing regimen of digoxin in adult patients. J Pharm Health Care Sci (2015) 0.75
Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis. J Pharm Health Care Sci (2016) 0.75
Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart Vessels (2017) 0.75
Temporal change of myocardial tissue character is associated with left ventricular reverse remodeling in patients with dilated cardiomyopathy: A cardiovascular magnetic resonance study. J Cardiol (2016) 0.75
Features of trunk muscle wasting during acute care and physical function recovery with aortic disease. J Cachexia Sarcopenia Muscle (2022) 0.75
Erratum to: Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Heart Vessels (2016) 0.75
Prognostic Value of Psoas Muscle Area and Density in Patients Who Undergo Cardiovascular Surgery. Can J Cardiol (2017) 0.75
Associations between kidney function and outcomes of comprehensive cardiac rehabilitation in patients with heart failure. Clin Res Cardiol (2021) 0.75
Effect of carvedilol on atrial remodeling in canine model of atrial fibrillation. Cardiovasc Diagn Ther (2014) 0.75
Erratum to: Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation. Heart Vessels (2017) 0.75
Subacute pneumothorax contralateral to the venous access site associated with atrial lead perforation in a patient who was receiving corticosteroid therapy. J Arrhythm (2017) 0.75
Prognostic Usefulness of Arm and Calf Circumference in Patients ≥65 Years of Age With Cardiovascular Disease. Am J Cardiol (2016) 0.75